Cargando…
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Autores principales: | Naranbhai, Vivek, Nathan, Anusha, Kaseke, Clarety, Berrios, Cristhian, Khatri, Ashok, Choi, Shawn, Getz, Matthew A., Tano-Menka, Rhoda, Ofoman, Onosereme, Gayton, Alton, Senjobe, Fernando, Zhao, Zezhou, St Denis, Kerri J., Lam, Evan C., Carrington, Mary, Garcia-Beltran, Wilfredo F., Balazs, Alejandro B., Walker, Bruce D., Iafrate, A. John, Gaiha, Gaurav D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969090/ https://www.ncbi.nlm.nih.gov/pubmed/35364034 http://dx.doi.org/10.1016/j.cell.2022.03.022 |
Ejemplares similares
-
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
por: Naranbhai, Vivek, et al.
Publicado: (2022) -
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts
por: Kaseke, Clarety, et al.
Publicado: (2021) -
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
por: Nathan, Anusha, et al.
Publicado: (2021) -
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
por: Naranbhai, Vivek, et al.
Publicado: (2022) -
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2021)